Year: 2007
Type: dissertation
Abstract: What’s in a name? Since the first description of age-related macular degeneration \nin 1874 as “Symmetrical central choroido-retinal disease occurring in senile persons”, \n1 over 20 different names have been given to this disorder, often reflecting the \npathophysiological thinking at a certain time. Because there was need for an internationally \naccepted classification, the International ARM Epidemiological Study \nGroup named all signs of age-related macular changes age-related maculopathy \n(ARM), and its end stages, age-related macular degeneration (AMD) following the \nconvention at that time.2 Both the laymen and the medical public found these two \nnames confusing, so gradually all ARM was called AMD, to be divided in early and \nlate AMD. Recently it was proposed to use AMD as an acronym for “Aging Macula \nDisorder”, essentially the same disease as age-related macular degeneration, for \nthe following reasons.3 Age-related does not differentiate between juvenile macular \ndisease and that associated with old age. Aging better describes the process of \nbecoming older. Although AMD is a complex disorder with a large genetic component, \nthe lifelong changes in the retinal pigment epithelium (RPE) and surrounding \ntissues in the macula seem a key component in its pathogenesis. Patients do not \nlike to hear associations with senility anymore, nor with degeneration. Finally, it \nis not clear if and when early or late AMD becomes a disease, therefore we prefer \ncalling it a disorder. Thus we opted for using aging macula disorder as the basis for \nAMD in this thesis.
Author: Sharmila S. Boekhoorn
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2102942590
